Post by misty on Mar 22, 2007 8:44:57 GMT -5
VYVANSE Approved by FDA - Big Money Involved Too!
A couple of months ago we reported that Shire
Pharmaceuticals was looking to receive
approval on their third medication for the
treatment of ADHD named VYVANSE, and now they
have received it from the FDA. This new
medication will go along with Shire's two
other products for ADHD, Daytrana, a
methylphenadate patch worn by children on the
hip, and the somewhat controversial ADDerall
XR. All three products are once per day dosing.
The product is expected to be on the market
by the summer of 2007, and is expected to
generate a lot of money for Shire. In fact,
Shire is so fond of stimulants for the
treatment of ADHD that they paid
$2,600,000,000 (yes, that's 2.6 Billion
dollars) for New river Pharmaceuticals, the
company that actually developed Vyvanse. Read
more in the press release below about the new
medication, the money, and the companies.
Press Release - VYVANSE - February 23, 2007
FOR IMMEDIATE RELEASE
Shire and New River Pharmaceuticals Announce
FDA Approval of the First and Only Stimulant
Prodrug VYVANSE (lisdexamfetamine
dimesylate) as a Novel Treatment for ADHD.
Read the ENTIRE press release... -
adhdnewsletter.com/vyvanse_approved_fda
A couple of months ago we reported that Shire
Pharmaceuticals was looking to receive
approval on their third medication for the
treatment of ADHD named VYVANSE, and now they
have received it from the FDA. This new
medication will go along with Shire's two
other products for ADHD, Daytrana, a
methylphenadate patch worn by children on the
hip, and the somewhat controversial ADDerall
XR. All three products are once per day dosing.
The product is expected to be on the market
by the summer of 2007, and is expected to
generate a lot of money for Shire. In fact,
Shire is so fond of stimulants for the
treatment of ADHD that they paid
$2,600,000,000 (yes, that's 2.6 Billion
dollars) for New river Pharmaceuticals, the
company that actually developed Vyvanse. Read
more in the press release below about the new
medication, the money, and the companies.
Press Release - VYVANSE - February 23, 2007
FOR IMMEDIATE RELEASE
Shire and New River Pharmaceuticals Announce
FDA Approval of the First and Only Stimulant
Prodrug VYVANSE (lisdexamfetamine
dimesylate) as a Novel Treatment for ADHD.
Read the ENTIRE press release... -
adhdnewsletter.com/vyvanse_approved_fda
